14-Aug-2026
Trump administration proposes closing loophole for food ingredients
Seeking Alpha News (Tue, 11-Aug 5:15 AM ET)
Colgate-Palmolive Delivers Broad-Based Growth in Q2 2026 Amid Higher Margins and Strong Investment
Market Chameleon (Fri, 31-Jul 3:32 AM ET)
Colgate Announces 2nd Quarter 2026 Results
Business Wire (Fri, 31-Jul 6:55 AM ET)
Colgate-Palmolive Webcasts 2026 Second Quarter Earnings Conference Call July 31, 2026 - 8:30 a.m. ET
Business Wire (Fri, 17-Jul 9:30 AM ET)
Colgate Declares Regular Quarterly Dividend
Business Wire (Thu, 11-Jun 4:35 PM ET)
Casey's Announces Addition of Finance Leader Stanley J. Sutula III to its Board of Directors
Business Wire (Mon, 8-Jun 4:00 PM ET)
NYSE Content Update: PointFive Raises $60 Million to Redefine Efficiency
PRNewswire (Mon, 8-Jun 8:55 AM ET)
Colgate-Palmolive Webcasts Fireside Chat at the dbAccess Global Consumer Conference
Business Wire (Wed, 20-May 9:30 AM ET)
Colgate Delivers Strong Organic Growth and Expands Productivity Program for 2026
Market Chameleon (Fri, 1-May 3:31 AM ET)
Has CL been a good buy before earnings?
Market Chameleon (Wed, 15-Apr 6:13 AM ET)
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.
Colgate-Palmolive Company trades on the NYSE stock market under the symbol CL.
As of August 14, 2026, CL stock price declined to $91.95 with 2,841,900 million shares trading.
CL has a beta of 0.22, meaning it tends to be less sensitive to market movements. CL has a correlation of 0.02 to the broad based SPY ETF.
CL has a market cap of $73.70 billion. This is considered a Large Cap stock.
Last quarter Colgate-Palmolive Company reported $5 billion in Revenue and $.99 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.04.
In the last 3 years, CL traded as high as $109.30 and as low as $67.62.
The top ETF exchange traded funds that CL belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
CL has underperformed the market in the last year with a price return of +11.1% while the SPY ETF gained +21.5%. However, in the short term, CL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.1% vs +4.0% return in SPY. But in the last 2 weeks, CL shares have been beat by the market, returning +0.7% compared to an SPY return of +3.9%.
CL support price is $91.29 and resistance is $94.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CL shares will trade within this expected range on the day.